Royalty Pharma (RPRX) News Today $36.85 +0.01 (+0.03%) Closing price 10/23/2025 04:00 PM EasternExtended Trading$36.85 0.00 (0.00%) As of 10/23/2025 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RPRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Royalty Pharma PLC $RPRX Shares Purchased by Cookson Peirce & Co. Inc.October 23 at 6:12 AM | marketbeat.comCullen Frost Bankers Inc. Increases Stock Holdings in Royalty Pharma PLC $RPRXOctober 23 at 6:02 AM | marketbeat.comAllspring Global Investments Holdings LLC Has $881,000 Stake in Royalty Pharma PLC $RPRXOctober 23 at 4:06 AM | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) Short Interest UpdateOctober 21 at 4:52 AM | marketbeat.comAllianz Asset Management GmbH Increases Stock Position in Royalty Pharma PLC $RPRXOctober 21 at 4:08 AM | marketbeat.comRoyalty Pharma PLC $RPRX Shares Bought by TD Asset Management IncOctober 21 at 3:46 AM | marketbeat.comNordea Investment Management AB Boosts Position in Royalty Pharma PLC $RPRXOctober 19, 2025 | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.22October 18, 2025 | marketbeat.comRoyalty Pharma Declares Fourth Quarter 2025 DividendOctober 17, 2025 | globenewswire.comAberdeen Group plc Grows Position in Royalty Pharma PLC $RPRXOctober 17, 2025 | marketbeat.comS Bank Fund Management Ltd Buys Shares of 43,508 Royalty Pharma PLC $RPRXOctober 16, 2025 | marketbeat.comMorningstar Investment Management LLC Acquires Shares of 8,307 Royalty Pharma PLC $RPRXOctober 15, 2025 | marketbeat.comCallan Family Office LLC Buys Shares of 16,418 Royalty Pharma PLC $RPRXOctober 14, 2025 | marketbeat.comRoyalty Pharma (RPRX) Valuation: Is There More Upside After This Year’s 40% Rally?October 13, 2025 | finance.yahoo.com3 Healthcare Stocks We Keep Off Our RadarOctober 13, 2025 | finance.yahoo.comRoyalty Pharma PLC $RPRX Shares Sold by Board of the Pension Protection FundOctober 12, 2025 | marketbeat.comInspire Investing LLC Buys 22,436 Shares of Royalty Pharma PLC $RPRXOctober 12, 2025 | marketbeat.comKLP Kapitalforvaltning AS Increases Position in Royalty Pharma PLC $RPRXOctober 11, 2025 | marketbeat.comBelpointe Asset Management LLC Purchases New Position in Royalty Pharma PLC $RPRXOctober 11, 2025 | marketbeat.comMorgan Stanley Maintains Royalty Pharma (RPRX) Overweight RecommendationOctober 11, 2025 | msn.comRoyalty Pharma price target lowered to $54 from $55 at Morgan StanleyOctober 10, 2025 | msn.comRoyalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025October 9, 2025 | globenewswire.comRoyalty Pharma (NASDAQ:RPRX) Raised to Buy (B-) at Weiss RatingsOctober 9, 2025 | marketbeat.comRoyalty Pharma PLC $RPRX Position Increased by Robeco Institutional Asset Management B.V.October 4, 2025 | marketbeat.comRoyalty Pharma PLC (NASDAQ:RPRX) Given Average Rating of "Buy" by AnalystsOctober 3, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Upgraded by The Goldman Sachs Group to "Strong-Buy" RatingOctober 2, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of Royalty Pharma (RPRX) with Buy RecommendationOctober 1, 2025 | msn.comRoyalty Pharma initiated with a Buy at Goldman SachsSeptember 30, 2025 | msn.comRoyalty Pharma appoints Ted Love as lead independent directorSeptember 29, 2025 | msn.comRoyalty Pharma Appoints Dr. Ted W. Love As Lead Independent DirectorSeptember 29, 2025 | globenewswire.comOverbrook Management Corp Trims Position in Royalty Pharma PLC $RPRXSeptember 29, 2025 | marketbeat.comAssessing Royalty Pharma (RPRX): Is the Recent Outperformance Reflected in Its Current Valuation?September 27, 2025 | finance.yahoo.comBank Pictet & Cie Europe AG Cuts Holdings in Royalty Pharma PLC $RPRXSeptember 27, 2025 | marketbeat.comRuffer LLP Makes New $6.41 Million Investment in Royalty Pharma PLC $RPRXSeptember 25, 2025 | marketbeat.comRoyalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for GrowthSeptember 24, 2025 | msn.comRoyalty Pharma plc (RPRX) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum TranscriptSeptember 23, 2025 | seekingalpha.comRidgewood Investments LLC Sells 11,236 Shares of Royalty Pharma PLC $RPRXSeptember 22, 2025 | marketbeat.comWedge Capital Management L L P NC Purchases 200,122 Shares of Royalty Pharma PLC $RPRXSeptember 21, 2025 | marketbeat.comMn Services Vermogensbeheer B.V. Purchases New Shares in Royalty Pharma PLC $RPRXSeptember 21, 2025 | marketbeat.comRoyalty Pharma to Present at Bernstein’s 2nd Annual Healthcare ForumSeptember 19, 2025 | markets.businessinsider.comRoyalty Pharma to Present at Bernstein's 2nd Annual Healthcare ForumSeptember 19, 2025 | globenewswire.comUBS Sticks to Their Hold Rating for Royalty Pharma (RPRX)September 17, 2025 | theglobeandmail.comTD Cowen Maintains a Buy on Royalty Pharma (RPRX)September 17, 2025 | insidermonkey.com1 Safe-and-Steady Stock with Promising Prospects and 2 We IgnoreSeptember 17, 2025 | finance.yahoo.comStrs Ohio Invests $1.89 Million in Royalty Pharma PLC $RPRXSeptember 17, 2025 | marketbeat.comRoyalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 ReceiptsSeptember 16, 2025 | finance.yahoo.comPacific Capital Partners Ltd Cuts Holdings in Royalty Pharma PLC $RPRXSeptember 16, 2025 | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Increases Stock Position in Royalty Pharma PLC $RPRXSeptember 15, 2025 | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Downgraded to Hold Rating by Wall Street ZenSeptember 15, 2025 | marketbeat.comEmpowered Funds LLC Makes New $8.01 Million Investment in Royalty Pharma PLC $RPRXSeptember 13, 2025 | marketbeat.com Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼1.410.57▲Average Medical News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼1112▲RPRX Articles Average Week Get the Latest News and Ratings for RPRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Royalty Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Zoetis News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Nektar Therapeutics News Today Pacira BioSciences News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredBuffett’s Retirement PlayIn 2022, when Larry Benedict called the peak of the market, those who stayed in oil were slaughtered. Meanw...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
